Münevver Demir

4.3k total citations · 1 hit paper
95 papers, 2.3k citations indexed

About

Münevver Demir is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Münevver Demir has authored 95 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 39 papers in Hepatology and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Münevver Demir's work include Liver Disease Diagnosis and Treatment (58 papers), Diet, Metabolism, and Disease (20 papers) and Liver Disease and Transplantation (16 papers). Münevver Demir is often cited by papers focused on Liver Disease Diagnosis and Treatment (58 papers), Diet, Metabolism, and Disease (20 papers) and Liver Disease and Transplantation (16 papers). Münevver Demir collaborates with scholars based in Germany, United States and Poland. Münevver Demir's co-authors include Hans‐Michael Steffen, Sonja Lang, Tobias Goeser, Anna Martin, Philipp Kasper, Fabian Kütting, Frank Tacke, Christoph Roderburg, Bernd Schnabl and Alexander Wree and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Münevver Demir

87 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NAFLD and cardiovascular diseases: a clinical review

2020 397 citations Philipp Kasper, Anna Martin et al. profile →

Peers

Countries citing papers authored by Münevver Demir

Since Specialization

Citations

This map shows the geographic impact of Münevver Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Münevver Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Münevver Demir more than expected).

Fields of papers citing papers by Münevver Demir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Münevver Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Münevver Demir. The network helps show where Münevver Demir may publish in the future.

Co-authorship network of co-authors of Münevver Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Münevver Demir. A scholar is included among the top collaborators of Münevver Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Münevver Demir. Münevver Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Liver‐Heart Score for Early Detection of Myocardial Contractile Dysfunction in Cirrhosis by Strain Imaging 2025 ·Liver International ·(unknown), Simona Bota, (unknown), Peter Höfer, Michael Hackl, (unknown), Hannes Alber, Raphael Mohr, Alexander Wree, (unknown), Cornelius Engelmann, Münevver Demir, Frank Tacke, Markus Peck‐Radosavljevic	0
2	Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma 2025 ·Liver International ·(unknown), (unknown), Minh D. Phan, Burcin Özdirik, Hilmar Berger, (unknown), (unknown), Janett Fischer, (unknown), Florian van Bömmel, (unknown), Kai Kappert, R Tauber, Tobias Puengel, Cornelius Engelmann, Münevver Demir, Frank Tacke, Raphael Mohr	1
3	Liver fat as risk factor of hepatic and cardiometabolic diseases 2023 ·Obesity Reviews ·Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, Nikolaos Perakakis	14
4	Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real‐world cohort 2023 ·Alimentary Pharmacology & Therapeutics ·(unknown), Münevver Demir, Alexander Wree, Tom Luedde, Sven H. Loosen, Tobias Müller, Frank Tacke, Christoph Roderburg, Raphael Mohr	35
5	Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome 2023 ·Hepatology ·Cynthia L. Hsu, Sonja Lang, Münevver Demir, Derrick E. Fouts, Peter Stärkel, Bernd Schnabl	18
6	The role of the circadian clock in the development, progression, and treatment of non‐alcoholic fatty liver disease 2023 ·Acta Physiologica ·Leonardo Vinícius Monteiro de Assis, Münevver Demir, Henrik Oster	15
7	Validation of risk scores for allograft failure after liver transplantation in Germany: a retrospective cohort analysis 2023 ·Hepatology Communications ·Simon Moosburner, (unknown), (unknown), (unknown), Münevver Demir, (unknown), (unknown), Paul Viktor Ritschl, Brigitta Globke, Georg Lurje, Frank Tacke, Wenzel Schöning, Johann Pratschke, Robert Öllinger, Igor M. Sauer, Nathanael Raschzok	10
8	Management of alcoholic hepatitis: A clinical perspective 2023 ·Liver International ·Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, Münevver Demir	19
9	Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice 2022 ·Hepatology International ·Phillipp Hartmann, Yi Duan, Yukiko Miyamoto, Münevver Demir, Sonja Lang, (unknown), Patrick Stern, Dennis S. Yamashita, (unknown), Lars Eckmann, Bernd Schnabl	22
10	Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling in Male Offspring of Obese Mice 2022 ·International Journal of Molecular Sciences ·Philipp Kasper, (unknown), Christina Vohlen, (unknown), (unknown), (unknown), Inga Bae‐Gartz, (unknown), Alexander Quaas, Björn Schumacher, Münevver Demir, Martin Bürger, Sonja Lang, Anna Martin, Hans‐Michael Steffen, Tobias Goeser, Jörg Dötsch, Miguel A. Alejandre Alcázar	8
11	Real‐life experiences with bulevirtide for the treatment of hepatitis delta—48 weeks data from a German centre 2022 ·Liver International ·(unknown), Jörg Hofmann, K. Lutz, Frank Tacke, Münevver Demir	19
12	Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial 2022 ·Journal of Global Antimicrobial Resistance ·Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, (unknown), (unknown), Martin Kluge, Tobias Puengel, Münevver Demir, Robert Röhle, Theresa Keller, Christoph Ruwwe‐Glösenkamp, Martin Witzenrath, Norbert Suttorp, Christof von Kalle, Leif Erik Sander, Christoph Jochum, Frank Tacke	8
13	The fecal mycobiome in non-alcoholic fatty liver disease 2021 ·Journal of Hepatology ·Münevver Demir, Sonja Lang, Phillipp Hartmann, Yi Duan, Anna Martin, Yukiko Miyamoto, Marina Bondareva, (unknown), Yanhan Wang, Philipp Kasper, Corinna Bang, Christoph Roderburg, Frank Tacke, Hans‐Michael Steffen, Tobias Goeser, Andrey Kruglov, Lars Eckmann, Peter Stärkel, Derrick E. Fouts, Bernd Schnabl	131
14	Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease 2021 ·Liver International ·Sonja Lang, Anna Martin, Xinlian Zhang, Fedja Farowski, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild, Marcin Krawczyk, Angela Nowag, (unknown), Claus Jürgen Scholz, Philipp Kasper, Christoph Roderburg, Raphael Mohr, Frank Lammert, Frank Tacke, Bernd Schnabl, Tobias Goeser, Hans‐Michael Steffen, Münevver Demir	22
15	Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis 2020 ·Liver International ·Sonja Lang, Münevver Demir, Yi Duan, Anna Martin, Bernd Schnabl	32
16	In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease? 2020 ·International Journal of Molecular Sciences ·Raphael Mohr, Burcin Özdirik, (unknown), Alexander Wree, Münevver Demir, Frank Tacke, Christoph Roderburg	11
17	Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors 2020 ·PLoS ONE ·(unknown), Raphael Mohr, Lukas Geisler, (unknown), Alexander Wree, Münevver Demir, Fabian Benz, Joeri Lambrecht, Sven H. Loosen, Frank Tacke, Christoph Roderburg, Henning Jann, Burcin Özdirik	4
18	Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies 2020 ·Journal of Clinical Medicine ·Burcin Özdirik, (unknown), (unknown), Lukas Geisler, Raphael Mohr, Münevver Demir, (unknown), Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann, Christoph Roderburg	10
19	Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study 2020 ·Journal of Clinical Medicine ·Burcin Özdirik, (unknown), Raphael Mohr, Lukas Geisler, Alexander Wree, (unknown), Münevver Demir, Mihael Vucur, Sven H. Loosen, Fabian Benz, Markus Reiß, Bertram Wiedenmann, Frank Tacke, Henning Jann, (unknown), Christoph Roderburg	8
20	Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients 2016 ·Medicine ·Münevver Demir, (unknown), Sonja Lang, Christoph Schramm, Andrea Bowe, (unknown), Fabian Kütting, Tobias Goeser, Hans‐Michael Steffen	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact